Takeda Pharmaceutical's R&D expenses FY 2018-2022
In fiscal year 2022, the research and development (R&D) expenses of Takeda Pharmaceutical Co., Ltd. accounted for approximately 633.3 billion Japanese yen, marking the highest expenditure over a five-year period. Fiscal year 2018 marked the lowest expenses at around 368.3 billion yen.